You are not currently logged in.
Access JSTOR through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Ongoing Immunoglobulin Somatic Mutation in Germinal Center B Cell-Like but Not in Activated B Cell-Like Diffuse Large Cell Lymphomas
Izidore S. Lossos, Ash A. Alizadeh, Michael B. Eisen, Wing C. Chan, Patrick O. Brown, David Botstein, Louis M. Staudt and Ronald Levy
Proceedings of the National Academy of Sciences of the United States of America
Vol. 97, No. 18 (Aug. 29, 2000), pp. 10209-10213
Published by: National Academy of Sciences
Stable URL: http://www.jstor.org/stable/123338
Page Count: 5
You can always find the topics here!Topics: B lymphocytes, Lymphoid tissue, Genetic mutation, Somatic mutation, Tumors, Specimens, Gene expression, Blood, Lymphoma, DNA
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
B cell diffuse large cell lymphoma (B-DLCL) is a heterogeneous group of tumors, based on significant variations in morphology, clinical presentation, and response to treatment. Gene expression profiling has revealed two distinct tumor subtypes of B-DLCL: germinal center B cell-like DLCL and activated B cell-like DLCL. In a separate study, we determined that B-DLCL can also be subdivided into two groups based on the presence or absence of ongoing Ig gene hypermutation. Here, we evaluated the correlation between these B-DLCL subtypes established by the two different methods. Fourteen primary B-DLCL cases were studied by gene expression profiling using DNA microarrays and for the presence of ongoing mutations in their Ig heavy chain gene. All seven cases classified as germinal center B cell-like DLCL by gene expression showed the presence of ongoing mutations in the Ig genes. Five of the seven cases classified by gene expression as activated B cell-like DLCL had no ongoing somatic mutations, whereas, in the remaining two cases, a single point mutation was observed in only 2 of 15 and 21 examined molecular clones of variable heavy (VH) chain gene, respectively. These two cases were distantly related to the rest of the activated B cell-like DLCL tumors by gene expression. Our findings validate the concept that lymphoid malignancies are derived from cells at discrete stages of normal lymphocyte maturation and that the malignant cells retain the genetic program of those normal cells.
Proceedings of the National Academy of Sciences of the United States of America © 2000 National Academy of Sciences